{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:08:54Z","timestamp":1780448934077,"version":"3.54.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1093\/ndt\/gfy001","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T02:38:10Z","timestamp":1514947090000},"page":"1968-1976","source":"Crossref","is-referenced-by-count":14,"title":["Comparative efficacy of individual renin\u2013angiotensin system inhibitors on major renal outcomes in diabetic kidney disease: a network meta-analysis"],"prefix":"10.1093","volume":"33","author":[{"given":"Juyu","family":"Cai","sequence":"first","affiliation":[{"name":"Cardiovascular Research Center, Shantou University Medical College, Shantou, China"},{"name":"Department of Internal Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianxi","family":"Huang","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Cardiology, Shantou University Medical College, Shantou, China"},{"name":"Intensive Care Unit, The First Affiliated Hospital of Shantou University Medical College, Shantou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongsheng","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian","family":"Peng","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, The Fifth People's Hospital of Shenzhen City, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoqian","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of respiratory medicine, Zhangjiajie City Hospital, Zhangjiajie, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B1","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Vos","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B3","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM199910073411506","article-title":"Nephropathy in patients with type 2 diabetes mellitus","volume":"341","author":"Ritz","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B4","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.ajkd.2012.07.005","article-title":"KDOQI clinical practice guideline for diabetes and CKD: 2012 update","volume":"60","author":"National Kidney Foundation","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B5","first-page":"CD006257","article-title":"Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease","volume":"4","author":"Strippoli","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B6","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1161\/01.CIR.0000090572.51900.92","article-title":"Should evidence-based proof of drug efficacy be extrapolated to a \u2018class of agents\u2019?","volume":"108","author":"Furberg","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B7","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/bmj.321.7274.1440","article-title":"Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study","volume":"321","author":"Mogensen","year":"2000","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ki.2008.204","article-title":"Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy","volume":"74","author":"Bakris","year":"2008","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1291\/hypres.30.325","article-title":"Effects of monotherapy of temocapril or candesartan with dose increments or combination therapy with both drugs on the suppression of diabetic nephropathy","volume":"30","author":"Ogawa","year":"2007","journal-title":"Hypertens Res"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/0003-4819-148-1-200801010-00190","article-title":"Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease","volume":"148","author":"Kunz","year":"2008","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B11","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/ndt\/gfq792","article-title":"Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials","volume":"26","author":"Maione","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B12","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(14)62459-4","article-title":"Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis","volume":"385","author":"Palmer","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B13","doi-asserted-by":"crossref","first-page":"f6008","DOI":"10.1136\/bmj.f6008","article-title":"Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and Bayesian network meta-analysis","volume":"347","author":"Wu","year":"2013","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B14","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/ajh.2008.206","article-title":"Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis","volume":"21","author":"Sarafidis","year":"2008","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B15","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2015.10.011","article-title":"Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials","volume":"67","author":"Xie","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B16","author":"Higgins","year":"2011"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B17","author":"Agency for Healthcare Research and Quality"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B19","article-title":"Cochrane Kidney and Transplant Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs))","author":"Russell"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B20","article-title":"Cochrane Metabolic and Endocrine Disorders Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs))","author":"Richter"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B21","first-page":"1","article-title":"KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/01.HYP.0000190585.54734.48","article-title":"Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes","volume":"46","author":"Bakris","year":"2005","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B23","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/ki.1996.480","article-title":"Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy","volume":"50","author":"Bakris","year":"1996","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B24","doi-asserted-by":"crossref","first-page":"I237","DOI":"10.1161\/01.HYP.19.2_Suppl.II237","article-title":"Angiotensin converting enzyme inhibitors versus calcium antagonists in the treatment of diabetic hypertensive patients","volume":"19","author":"Ferder","year":"1992","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B25","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.ijcard.2012.04.058","article-title":"Effects of telmisartan on proteinuria or albuminuria: a meta-analysis of randomized trials","volume":"167","author":"Takagi","year":"2013","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B26","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/sim.4780111304","article-title":"Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design","volume":"11","author":"Frison","year":"1992","journal-title":"Statist Med"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B27","author":"Dias","year":"2011"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B28","author":"Dias","year":"2011"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B29","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B30","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1002\/sim.1875","article-title":"Combination of direct and indirect evidence in mixed treatment comparisons","volume":"23","author":"Lu","year":"2004","journal-title":"Statist Med"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B31","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/10618600.1998.10474787","article-title":"Alternative methods for monitoring convergence of iterative simulations","volume":"7","author":"Brooks","year":"1997","journal-title":"J Comput Graph Stat"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B32","doi-asserted-by":"crossref","first-page":"e1001454","DOI":"10.1371\/journal.pmed.1001454","article-title":"Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis","volume":"10","author":"Barth","year":"2013","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B33","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jclinepi.2008.10.001","article-title":"A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered","volume":"62","author":"Salanti","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B36","author":"Salanti"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2288-9-2","article-title":"Assessment of regression-based methods to adjust for publication bias through a comprehensive simulation study","volume":"9","author":"Moreno","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B38","author":"World Health Organization"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B39","first-page":"1358","article-title":"ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?","volume":"15","author":"Lewis","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B40","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/01.ASN.0000093368.27046.3C","article-title":"ACE inhibition versus angiotensin receptor blockade: which is better for renal and cardiovascular protection?","volume":"15","author":"Laverman","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B41","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2215\/CJN.11511114","article-title":"Albuminuria is an appropriate therapeutic target in patients with CKD: the pro view","volume":"10","author":"Lambers","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/0003-4819-148-1-200801010-00190","article-title":"Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease","volume":"148","author":"Kunz","year":"2008","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B43","doi-asserted-by":"crossref","first-page":"e1560","DOI":"10.1097\/MD.0000000000001560","article-title":"Effects of ACEIs versus ARBs on proteinuria or albuminuria in primary hypertension: a meta-analysis of randomized trials","volume":"94","author":"Xu","year":"2015","journal-title":"Medicine"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B44","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00125-011-2398-8","article-title":"Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis","volume":"55","author":"Vejakama","year":"2012","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B45","doi-asserted-by":"crossref","first-page":"e1001971","DOI":"10.1371\/journal.pmed.1001971","article-title":"Cardiovascular and renal outcomes of renin-angiotensin system blockade in adult patients with diabetes mellitus: a systematic review with network meta-analyses","volume":"13","author":"Catala-Lopez","year":"2016","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Res Synth Methods"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B47","doi-asserted-by":"crossref","first-page":"d4909","DOI":"10.1136\/bmj.d4909","article-title":"Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study","volume":"343","author":"Song","year":"2011","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B48","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/01.CIR.0000047526.08376.80","article-title":"Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies","volume":"107","author":"Ruggenenti","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2018110203510529700_gfy001-B49","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/ndt\/17.8.1413","article-title":"Optimal dose of losartan for renoprotection in diabetic nephropathy","volume":"17","author":"Andersen","year":"2002","journal-title":"Nephrol Dial Transplant"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/33\/11\/1968\/26182594\/gfy001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T07:10:19Z","timestamp":1719731419000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/33\/11\/1968\/4951656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,3,22]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfy001","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,3,22]]}}}